NCT02679885View on ClinicalTrials.gov

Teriflunomide Male Transmission Study

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

September 30, 2018

Conditions
Multiple Sclerosis
Trial Locations (1)

06418

Multiple Sclerosis Treatment Center at Griffin Hospital, Derby

All Listed Sponsors
lead

Griffin Hospital

OTHER

NCT02679885 - Teriflunomide Male Transmission Study | Biotech Hunter | Biotech Hunter